On July 11, 2012, Merus Labs International Inc. acquired Emselex®/Enablex®. Stewart Muglich and Victor Dudas of our Corporate Finance & Securities Group handled the debt facility between Merus and PDL BioPharma Inc., a company that supports the healthcare industry with creative financing solutions, assisted by Amaan Gangji and Kevin MacDonald. The transaction involved counsel from Toronto, New York, Switzerland, the Netherlands and Luxembourg.
Related Content
Assignment Collection and Filing Obligations
Any developer that enters into a presale purchase agreement in respect of “development property” is obligated to file with the CSAIR a report within 30 ... Continued
Clark Wilson Blogs
Several members of our firm publish blogs on legal topics. Please see the descriptions below, and follow the links to visit each blog. The Clark ... Continued
Timing of an occurrence matters
R.C. Heating & Gasfitting Ltd. v. The Sovereign General Insurance Company, 2017 BCSC 1916 Most liability policies may be classified as either occurrence or claims-made ... Continued